Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237091 · ClinicalTrials.gov registry record · NA
Enhancing Corticospinal Excitability to Improve Functional Recovery
A NA study, sponsored by Shepherd Center, Atlanta GA.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03237091: Completed NA study, sponsored by Shepherd Center, Atlanta GA.
NCT03237091 is a NA study that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03237091, a NA study, has completed, sponsored by Shepherd Center, Atlanta GA.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Research indicates that increasing brain excitability might help improve hand function in people with spinal cord injury. Brain stimulation that uses electrodes placed on the surface of the scalp (also called "non-invasive brain stimulation") increases brain excitability and has the potential to make it easier for the brain and nervous system to respond to arm and hand training. The purpose of this study is to compare four different types of stimulation for increasing brain excitability to determine which types are best for helping people with tetraplegia improve their ability to use their arms and hands. To fully evaluate the value of brain stimulation on arm and hand function, the investigators will also evaluate the effect of sham (fake) stimulation. Each participant will receive a single session of each of the five types of stimulation being tested.
Primary Outcome
The motor control outcome measure evaluates how quickly the participant can move their fingers. Participants will tap their thumb or index finger as fast as possible for 10 seconds at a time while a sensor counts the number of taps. The strength outcome measure evaluates the participant's hand strength. Participants will use their thumb and index finger to pinch a hand-held device that measures their strength.
Interventions
- OTHER bihemispheric transcranial pulsed current stimulation (tPCS)
- OTHER unihemispheric transcranial pulsed current stimulation (tPCS)
- OTHER bihemispheric transcranial direct current stimulation (tDCS)
- OTHER unihemispheric transcranial direct current stimulation (tDCS)
- OTHER sham-control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2019-09-27 |
| Phase | NA |
What the finished NCT03237091 record still lists
NCT03237091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which bihemispheric transcranial pulsed current stimulation (tPCS) is the first listed.
NCT03237091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03237091 about?
NCT03237091 is a clinical study titled "Enhancing Corticospinal Excitability to Improve Functional Recovery". Research indicates that increasing brain excitability might help improve hand function in people with spinal cord injury. Brain stimulation that uses electrodes placed on the surface of the scalp (also called "non-invasive brain stimulation") increases brain excitability and has the potential to mak...
What is the current status of trial NCT03237091?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-05-03. Estimated completion is 2019-09-27.
What interventions are being tested in trial NCT03237091?
The interventions under investigation include: bihemispheric transcranial pulsed current stimulation (tPCS) (OTHER), unihemispheric transcranial pulsed current stimulation (tPCS) (OTHER), bihemispheric transcranial direct current stimulation (tDCS) (OTHER), unihemispheric transcranial direct current stimulation (tDCS) (OTHER), sham-control (OTHER).
Who is sponsoring clinical trial NCT03237091?
This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03237091's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI